Qualigen Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Qualigen Therapeutics, Inc.
CIK #0001460702
EDGAR Form CIK 2011 - 2024
10-K [0001460702]
10-Q [0001460702]
3 [0001460702]
4 [0001460702]
8-K [0001460702]
D [0001460702]
SC 13D [0001460702]
SC 13G [0001460702]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sabby Management LLC Qualigen Therapeutics Inc [2021-12-06]
Greenblock Capital LLC Qualigen Therapeutics Inc [2020-06-01]
Sekisui Diagnostics LLC Qualigen Therapeutics Inc [2020-06-01]
Alpha Capital Anstalt Qualigen Therapeutics Inc [2020-05-28]
Baker Bros Advisors LP Ritter Pharmaceuticals Inc [2018-02-13]
Sabby Management LLC Ritter Pharmaceuticals Inc [2017-10-03]
Knoll Capital Management LP Ritter Pharmaceuticals Inc [2016-11-04]
Knoll Capital Management LP Ritter Pharmaceuticals Inc [2016-10-05]
Step Michael D Ritter Pharmaceuticals Inc [2016-02-25]
Stonehenge Partners LLC Ritter Pharmaceuticals Inc [2016-02-25]
View All
Form 3/4/5 Subject 2011 - 2024
Poirier Michael S.
Qualigen Therapeutics, Inc.
Kruger Kurt H
Emery Sidney W Jr
Ritter Ira E.
Arshad Tariq
Sinha Shishir K.
Korenberg Matthew E
Broidrick Amy S
Abdul-Ahad Wajdi
View All
Terms | Privacy | Guide
tony@aum13f.com